Sygnomics

Sygnomics is a personalized precision oncology startup that helps oncologists improve patient outcomes by accurately predicting each patient’s risk of disease progression and identifying specific therapies that could be effective against their cancer. Unlike current mutation-focused genetic testing reports, Sygnomics’

Sygnomics is a business in computational health.

Profile

Sygnomics is a personalized precision oncology startup that helps oncologists improve patient outcomes by accurately predicting each patient’s risk of disease progression and identifying specific therapies that could be effective against their cancer. Unlike current mutation-focused genetic testing reports, Sygnomics’ lab-developed test report is based on specific disease pathways driving the patient’s cancer, identified by […]

Sygnomics is positioned in computational health, a segment that rewards a clear, focused offering.

It is recorded at the Creative Destruction Lab alumni company stage.

Website: www.sygnomics.net